Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


TRIA Preps FDA Submission For OTC Skin Rejuvenating Laser, Files For IPO

This article was originally published in The Tan Sheet

Executive Summary

The aesthetic device maker plans to file a 510(k) this year with FDA for its OTC, non-ablative laser to treat facial wrinkles, supported in part by proceeds from an IPO worth up to $86.3 million. The hand-held device restricts a laser beam to fine “spot sizes” surrounded by untreated tissue.


Related Content

TRIA Beauty Alleges Laser Hair-Removal Center Mislead Customers, Files Suit


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts